Fraunhofer Institute for Cell Therapy and Immunology IZI. Immune Tolerance ^Hubs

Their research focus is on the development of new pharmacological treatment options for chronic inflammatory diseases that arise from dysregulated immune system in the skin, the gastrointestinal tract, the musculoskeletal or central nervous system. Although the respective diseaseas such as rheumatoid arthritis or multiple sclerosis are clearly distinct entities and differ considerably in their clinical manifestations they, share a loss of immunological self tolerance as a common pathogenic feature.